Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Visma acquires OutSmart, expanding its Benelux footprint in field service management software

Visma, European leader in cloud software, has acquired SaaS scale-up OutSmart, provider of field service management software for small and medium-sized businesses. OutSmart is based in the Netherlands and also operates in Belgium, Germany and Portugal. Joining Visma will allow OutSmart to accelerate its growth ambitions. OutSmart was founded in 2011 under the name WerkbonApp. Field service workers can use the digital work order to register their activities, after which the inside sales department processes them into invoices with a mouse click. The tool became an instant success. In 2019,

Growing demand for Quartzene® in cool roof applications – Svenska Aerogel delivers another order to a returning customer

The demand for Quartzene® in cool roof applications is increasing, especially in southern Europe. Svenska Aerogel's latest order exemplifies this. The order for 500 kg of Quartzene® was recently sent to the French distributor Novcoat. Novcoat will in turn distribute the material to the company Renovcoat, for use in cool roof solutions.[En bild som visar text, inomhus, transport Automatiskt genererad beskrivning]   Renovcoat sells anti-condensation paint and cool roof paint containing Quartzene® for its local French market and for overseas territories and Africa. The material from

Mentice publishes the company’s interim report for the period July – Sept 2022

CONTINUOUS STRONG DEMAND FROM THE HOSPITAL MARKET · Continued overall growth for the first nine months, mainly driven by Hospital and Strategic Alliances while Medical Device Industry remains on the same level as last year while remaining to be the largest contributor. · Larger order received for Ultrasound solutions during the quarter further articulating the opportunity within the Echocardiography market. · Executive team consisting of 5 standing members, furthermore, a consolidation of VIST software development to Gothenburg and a short-term freeze of hiring and consultants in

Bravida strengthens its customer offering and forms a new division, headed by Magnus Hamerslag

Bravida’s new Growth Segments Division brings together Technical Facility Management, Automation and Energy Management. The aim with this is to strengthen what we offer customers and to continue helping them achieve their energy efficiency, energy transition and CO\2\ reduction goals.By grouping the relevant areas in one division, we can take holistic responsibility for the entire property portfolio. Energy Management uses digital analysis to identify and implement energy improvement measures. Technical Facility Management is responsible for the maintenance and functioning of complex

HC Andersen Capital Events 26/10: Meet the top management in Qlife

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.Qlife - Company introductionMeet Qlife’s CEO Thomas Warthoe presenting an introduction to the company.Qlife’s home diagnostic platform Egoo Health addresses the following trends within healthcare: healthcare decentralization, chronic diseases in the increasing ageing population and lifestyle diseases. In the trend for home diagnostics, the company offers a very compelling solution, Qlife already has it CE approved with sales today; the next

Three French university hospitals select digital pathology solution from Sectra — join forces to speed up cancer diagnostics

Linköping, Sweden – October 26, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has received an order for its digital pathology solution from three university hospitals in southwestern France. The hospitals will complement their use of microscopes with a joint digital solution allowing the pathologists to review and collaborate around cases in a way that has not been possible before. Digital access to cases, tools for reviewing, diagnosing and collaborating, and efficient resource sharing create new ways to improve the treatment of

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

Asetek Unveils Most Advanced Desktop Liquid Cooling Technology To Date First Available In New ASUS ROG RYUO III ARGB Series CPU Coolers

Asetek’s Latest Innovations Specifically Optimized for AMD Ryzen™ 7000 and 5000 Series and Intel 13th & 12th Generation ProcessorsAalborg, Denmark – October 26, 2022 –– Asetek, the creator of the all-in-one liquid cooler, and  global leader in liquid cooling solutions for gaming PCs and DIY enthusiasts, and sim racing gear innovator, today announced its most advanced liquid cooling technology to date, first available in the ASUS ROG RYUO III ARGB Series CPU coolers. Asetek’s liquid cooling innovations continue to raise the bar for gamers looking for the ultimate gameplay experience, PC

Capivasertib Phase III trial met primary endpoints

26 October 2022 07:00 BST Capivasertib plus Faslodex significantly improved progression-free survival vs. Faslodex in CAPItello-291 Phase III trial in advanced HR-positive breast cancer Capivasertib, a potential first-in-class AKT inhibitor, combined with Faslodex could become a new option for patients in this setting regardless of biomarker status Positive high-level results from the CAPItello-291 Phase III trial showed that AstraZeneca's capivasertib in combination with Faslodex (fulvestrant) demonstrated a statistically significant and clinically meaningful improvement in

InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2023 Annual General Meeting

October 26, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced the composition of the Nomination Committee for the 2023 Annual General Meeting. The responsibility of the Nomination Committee is to present to the 2023 Annual General Meeting proposals regarding election of the Chairman of the Board and other members of the Board, fees and any other remuneration to the members of the Board as well as election and remuneration of the auditors.The Nomination Committee for the 2023 Annual General Meeting of InDex Pharmaceuticals Holding AB (publ) consists of: · Karl Tobieson,

Interim report January-September 2022: Best quarter to date – record for both sales and earnings

Third quarter · Order intake increased by 24 percent to 621 MSEK (502). · Net sales increased by 38 percent to 567 MSEK (412). · EBIT more than doubled to 69.4 MSEK (31.9). · The operating margin increased to 12.2 percent (7.8). · Profit after tax rose to 51.3 MSEK (21.7). · Earnings per share amounted to SEK 1.77 (0.75).    Nine months · Order intake increased by 36 percent to 1,949 MSEK (1,433). · Net sales increased to 1,540 MSEK (1,152). · EBIT tripled to 138.4 MSEK (46.4). · Profit after tax rose to 95.4 MSEK (25.2). · Earnings per share

Dicot AB (publ) brings forward publication of financial report for Q3 2022

Press release: Uppsala, October 26, 2022.Publication of Dicot's report for the third quarter will be brought forward to November 1, 2022. Previously announced date for publication was November 15, 2022.The reason why the company brings forward the financial report is that the financial statements will be ready faster than expected and that the board therefore sees no reason to delay publication.

Attendo third quarter report 2022: MORE CUSTOMERS AND BETTER MARKET CONDITIONS IN FINLAND AHEAD OF 2023

Attendo continues to attract more customers to its operations in the third quarter of 2022, which is shown in a sustained strong organic growth. Higher sick-leave numbers due to Covid, increasing inflation and challenges in finding qualified employees have, however, had negative impact on the result in the quarter. Ahead of 2023 we note clear improvements in market conditions in Finland, where new rules regarding staffing will be eased and renegotiations on contracts to reach sustainable terms is progressing according to plan.Comments from Martin Tivéus, Attendo president and CEO “We are

INIFY Laboratories - Laboratory and recruitment on track with positive market feedback

STOCKHOLM – October 26, 2022 – Inify Laboratories, a fully integrated digital ultramodern laboratory services within pathology that provides cancer diagnostics, is advancing towards opening of the company’s new laboratory, situated on Campus Solna close to Karolinska Institutet in Stockholm. “In an impressively short time, we have built a simulation lab where we further improve, test and verify our development work, ensuring that it fits well into the upcoming production environment,” says CEO Fredrik Palm at Inify Laboratories. The system has an optimized and standardized workflow

Invitation to Q3 Earnings Teleconference

Karnov Group (Nasdaq: KAR) will publish its financial report for the third quarter and first nine months 2022 on 9 November at around 08.00 a.m. CET and Management will host a webcasted telephone conference the same day at 09.00 a.m. CET.Karnov Group’s interim report for the period January – September 2022 will be published on Wednesday 9 November 2022 at around 8.00 a.m. CET. A webcasted telephone conference will be held at 09.00 a.m. CET the same day, where CEO Pontus Bodelsson and CFO Jonas Olin will present the report and answer questions.   You can follow the presentation via

REPORT ON THE THIRD QUARTER 2022

SOLID EBITA MARGIN OF 14% AND IMPROVED OPERATING CASH FLOW THIRD QUARTER 2022 · Net sales were SEK 7,576 m (5,545); an increase of 37%, of which -6% was organic growth. · Operating profit (EBITA) before items affecting comparability was SEK 1,057 m (879), corresponding to a margin of 14.0% (15.9%). · Items affecting comparability were SEK -326 m (-23) and were mainly related to activities in the previously announced global restructuring programs. Activities are progressing as planned and total estimated costs and savings from the programs remain as communicated before. ·

Quarterly Report Q3 2022

Very strong performance in the quarter Third quarter ·Net sales increased by 33% to SEK 31,820 M (23,930), with organic growth of 14% (7) and acquired net growth of 3% (2). Exchange-rates affected sales by 16 (–1). ·Very strong organic growth in Entrance Systems, Global Technologies and Americas, good growth in EMEIA, but organic sales declined in Asia Pacific. ·Six acquisitions with combined annual sales of about SEK 1,000 M were signed in the quarter. ·The US regulator will seek to block ASSA ABLOY’s proposed acquisition of the HHI division of Spectrum

Successful refinancing of capital structure

EnQuest PLC, 26 October 2022 Successful refinancing of capital structure Further to the announcement on 13 October 2022, EnQuest PLC ('EnQuest' or the 'Company' or the 'Group') is pleased to announce it has successfully concluded the refinancing of its debt facilities. The Company has secured a $500.0 million reserves based lending (the "RBL") facility with a $300.0 million uncommitted accordion, maturing in April 2027, and has also completed its offering of $305.0 million aggregate principal amount of 11.625% senior notes (the "Notes") due November 2027. The net proceeds from the

Issue of Equity and Director/PDMR Dealings

26 October 2022 IOG plc Issue of Equity and Director/PDMR Dealings IOG plc ("IOG", or "the Company"), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high return projects, announces the following dealings in its ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares"). Issue of Equity The Company has issued a total of 648,079 Ordinary Shares following the exercise of options ("Options") over 546,871 Ordinary Shares by Rupert Newall, CEO, as well as 101,208 Options by other IOG employees pursuant to Salary Sacrifice Share

Detection Technology Plc business review January-September 2022

Detection Technology Plc company announcement 26 October 2022 at 09:00 (EEST) DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-SEPTEMBER 2022 Detection Technology Q3 2022: Double-digit growth in sales, unsatisfactory profitability July-September 2022 highlights · Net sales increased by 17.5% to EUR 27.3 million (23.2) · Net sales of Industrial Solutions Business Unit (IBU) increased by 2.8% to EUR 3.9 (3.8) · Net sales of Medical Business Unit (MBU) increased by 24.0% to EUR 14.8 million (11.9) · Net sales of Security Business Unit (SBU) increased by 14.6% to EUR 8.5

FlexQubes report for the third quarter 2022

THIRD QUARTER 2022 · Order intake decreased by 9.6 percent to 36.7 MSEK (40.6). Adjusted for foreign exchange rate effects between the comparison periods, orders received decreased by 24.5 percent. · Net sales increased by 140 percent to 56.4 MSEK (23.5). Adjusted for foreign exchange rate effects between the comparison periods, net sales increased by 115 percent. · Operating profit before depreciation (EBITDA) amounted to 4.0 MSEK (-8.0) and operating profit before financial items (EBIT) amounted to 2.8 MSEK (-9.2). · Profit before tax amounted to 2.6 MSEK (-9.3). ·

New study shows Nevisense significantly improves US clinician’s decision-making beyond dermoscopy

STOCKHOLM, SWEDEN, — October 26, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a new clinical study has been published presenting the improvement that the Nevisense test provides over standard of care visual and dermoscopic evaluation. The article named “Electrical impedance spectroscopy significantly enhances correct biopsy choice for pigmented skin lesions beyond clinical evaluation and dermoscopy” has been published in the journal “Melanoma Research”. The study included 231 US

Loudspring Oyj: Q3 2022 Summary

Loudspring Oyj Company release 26 October 2022 at 9:00 (EET) Please note that this report is not a fully comprehensive report of all events, nor is it in any way a financial performance report. It is only a summary of the main events that have affected our business during the quarter and before the date of this report where separately indicated below. In the quarterly report we only comment highlights during the period. To get a comprehensive overview of the company’s businesses one should review additional documents such as the company description and the supplement to the

Bangkok,Thailand retains its name for “the Best City”

Bangkok, Thai capital voted Best Leisure City in the Asia-Pacific’ from Business Traveller Asia-Pacific readers and Condé Nast Traveler Readers’ Choice Awards 2022 also include Bangkok at No. 4 on ‘Best Cities in the World’   Bangkok has been voted the ‘Best Leisure City in the Asia-Pacific’ for the sixth consecutive time in the prestigious Business Traveller Asia-Pacific Awards 2022. It is also a record 11th time Bangkok has won the ‘Best Leisure City in the Asia-Pacific’ title since 2008. The title was not included in the 2021 awards, but returned this year to once again be

There are no items matching the current filter
There are no more items matching the current filter
Back to top